Do you think there is any possibility that the stock price could be in the high teens before approval? Reason I ask, is that it is possible (maybe unlikely) that a BO offer could come before approval. Reason I posit that is because everyone now knows that there is no problem with the drug (efficacy, side effects, etc.) and any acquirer would know the third party manufacturer and the problems identified. Easy enough for an acquirer to kick some tires and know ahead of time whether everything is satisfactory for an FDA approval this time around.
Market Data 
Markets 
AI
